Back to search

Bcg in Tumor Immunotherapy

Data up to Jan 2025

Published1978
Citations76
References233

Total Citations Per Year

Abstract

References (233)

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

1977 • 8,468 citations

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1976 • 2,290 citations

Cancer. A Comprehensive Treatise

1975 • 742 citations

Lymphocyte-Mediated Cytotoxicity And Blocking Serum Activity To Tumor Antigens

1974 • 651 citations

ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIA

1969 • 606 citations

ALTERATIONS OF MACROPHAGE FUNCTIONS BY MEDIATORS FROM LYMPHOCYTES

1971 • 507 citations

Effect of Bacillus Calmette-Guérin Infection on Transplanted Tumours in the Mouse

1959 • 501 citations

A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin

1976 • 478 citations

FACTORS AFFECTING THE RESPONSE OF IMMUNISED GUINEAPIGS TO ANTIGENIC STIMULUS

1949 • 472 citations

Endotoxin and Double Stranded RNA render Macrophages Cytotoxic

1971 • 448 citations

BCG lmmunotherapy of Malignant Melanoma

1974 • 430 citations

Macrophage content of tumours in relation to metastatic spread and host immune reaction

1974 • 380 citations

Immunotherapy of Cancer: Regression of Intradermal Tumors and Prevention of Growth of Lymph Node Metastases After Intralesional Injection of Living <italic>Mycobacterium bovis</italic>

1972 • 355 citations

Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.

1976 • 339 citations

Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo

1977 • 326 citations

MACROPHAGES IN SYNGENEIC ANIMAL TUMOURS

1972 • 295 citations

The role of the reticuloendothelial system in the host reaction to neoplasia

1962 • 295 citations

Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells

1977 • 288 citations

PARAQUAT POISONING

1976 • 280 citations

Suppression of Tumor Growth at the Site of Infection With Living Bacillus Calmette-Guérin

1971 • 270 citations

Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts.

1976 • 239 citations

Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens.

1976 • 238 citations

ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMA

1973 • 235 citations

Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non‐immunized semi‐syngeneic mice against a mouse lymphoma line

1975 • 230 citations

Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.

1969 • 219 citations

Complications of BCG Immunotherapy in Patients with Cancer

1973 • 215 citations

Immunotherapy of Cancer: Regression of Tumors after Intralesional Injection of Living Mycobacterium bovis

1971 • 213 citations

Immunotherapy of Cancer: Present Status of Trials in Man

1977 • 212 citations

Regulation of the Immune Response to Tumor Antigens

1976 • 207 citations

Induction of “natural killer” cells by BCG

1976 • 205 citations

Chemoimmunotherapy of Disseminated Malignant Melanoma with Dimethyl Triazeno Imidazole Carboxamide and Bacillus Calmette-Guérin

1974 • 197 citations

Discrimination Between Neoplastic and Non-Neoplastic Cells In Vitro by Activated Macrophages12

1974 • 191 citations

REGIONAL IMMUNOTHERAPY OF LUNG CANCER WITH INTRAPLEURAL B.C.G.

1976 • 188 citations

Immunopotentiation With BeG. I. Immune Response to Different Strains and Preparations2

1973 • 186 citations

Cancer, Differentiation and Embryonic Antigens: Some Central Problems

1974 • 183 citations

Immunological Factors in Human Sarcomas and Melanomas

1970 • 178 citations

TREATMENT AFTER EXPOSURE TO COLD

1972 • 160 citations

Prostaglandin-E1 for Interrupted Aortic-Arch in Neonate

1976 • 151 citations

Immunopotentiation with BCG. II. Modulation of the Response to Sheep Red Blood Cells2

1973 • 148 citations

Cell walls of mycobacteria and related organisms; Chemistry and immunostimulant properties

1975 • 146 citations

Natural Occurrence of Lymphocytes Showing Cytotoxic Activity to BALB/c Radiation-Induced Leukemia RL ♂ 1 Cells

1975 • 144 citations

DIETARY FAT AND DIETARY SUGAR.

1964 • 141 citations

Selection for Treatment in Spina Bifida Cystica

1973 • 139 citations

Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastasis.

1972 • 137 citations

BCG Immunotherapy of Pulmonary Growths from Intravenously Transferred Rat Tumour Cells

1973 • 119 citations

Counteraction of the blocking of cell‐mediated tumor immunity by inoculation of unblocking sera and splenectomy: immunotherapeutic effects on primary polyoma tumors in rats

1972 • 115 citations

Regulation of the Immune Response to Tumor Antigens

1976 • 114 citations

Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than those recovered from progressing sarcomas

1977 • 112 citations

Suppression of Urethan-Induced Lung Adenomas in Mice Treated with Trehalose-6,6-Dimycolate (Cord Factor) and Living Bacillus Calmette Guérin

1971 • 111 citations

Cord factor and related trehalose esters

1976 • 111 citations

Tumour‐specific immunity against spontneous rat tumours

1966 • 104 citations

Suppression of Murine Tumor Growth by Immune Reaction to the Bacillus Calmette-Guérin Strain of <italic>Mycobacterium bovis</italic>

1972 • 102 citations

Tumor Immunity in Hamsters Immunized with Fetal Tissues

1971 • 102 citations

Response of Syngeneic Murine Lymphomata to Immunotherapy in Relation to the Antigenicity of the Tumour

1972 • 99 citations

Brief Communication: Tumor Regression Caused by Endotoxins and Mycobacterial Fractions

1975 • 99 citations

Tumor Progression and Homeostasis

1976 • 98 citations

Non-specific and specific immunotherapy in patients with melanoma.

1972 • 96 citations

GRANULOMATOUS HEPATITIS: A COMPLICATION OF B.C.G. IMMUNOTHERAPY

1973 • 94 citations

Mechanisms of macrophage activation by Corynebacterium parvum

1975 • 90 citations

Tumor-Bound Immunoglobulins:in SituExpressions Of Humoral Immunity

1977 • 88 citations

Neoantigens on spontaneous and carcinogen‐induced rat tumours defined by in vitro lymphocytotoxicity assays

1974 • 87 citations

Immunotherapy of melanoma with BCG: Two fatalities following intralesional injection

1975 • 86 citations

Hazards and Complications of BCG Immunotherapy

1976 • 85 citations

Regional immunotherapy with intrapleural BCG for lung cancer

1976 • 84 citations

Immunotherapy of cancer : present status of trials in man

1978 • 82 citations

ALLERGIC IRRITABILITY

1924 • 80 citations

Delayed Cutaneous Reactions in the Rat

1962 • 79 citations

Enhancement of T suppressor activity in mice by high doses of BCG

1976 • 79 citations

Effect of X-irradiation on host-cell infiltration and growth of a murine fibrosarcoma

1977 • 78 citations

Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue.

1971 • 73 citations

Tumor suppression by cell walls of mycobacterium bovis attached to oil droplets.

1972 • 72 citations

Specific Tumor Immunity Induced with Soluble Materials: Restricted Range of Antigen Dose and of Challenge Tumor Load for Immunoprotection

1975 • 71 citations

Treatment of Acute Lymphoblastic Leukaemia: PRELIMINARY REPORT BY THE LEUKAEMIA COMMITTEE AND THE WORKING PARTY ON LEUKAEMIA IN CHILDHOOD

1971 • 69 citations

BCG immunotherapy of local subcutaneous growths and post‐surgical pulmonary metastases of a transplanted rat epithelioma of spontaneous origin

1973 • 69 citations

CRITICAL REVIEW OF PREVIOUSLY REPORTED CLINICAL TRIALS OF CANCER IMMUNOTHERAPY WITH NON‐SPECIFIC IMMUNOSTIMULANTS*

1976 • 68 citations

Influence of tumor antigen on maintenance versus depression of tumor-specific immunity.

1973 • 67 citations

Controlled trial of active immunotherapy in management of stage IIB malignant melanoma.

1977 • 67 citations

Immunological monitoring and immunotherapy in carcinoma of the lung

1976 • 67 citations

Tumor-Specific Vaccine Containing <italic>Mycobacterium bovis</italic> and Tumor Cells: Safety and Efficacy

1972 • 67 citations

Shared Antigens Between Mycobacterium bovis (BCG) and Neoplastic Cells2

1974 • 67 citations

Inhibition of Leukocyte Migration by Tumor-Associated Antigens in Soluble Extracts of Human Malignant Melanoma2

1975 • 67 citations

BCG Immunotherapy of a Rat Sarcoma

1973 • 66 citations

The macrophage and cancer.

1976 • 66 citations

BCG as Adjuvant Immunotherapy for Neoplasia

1977 • 66 citations

Tuberculin sensitivity in guinea-pigs after vaccination with varying doses of BCG of 12 different strains.

1976 • 62 citations

Regression of pulmonary metastatic disease associated with intralesional bcg therapy of intracutaneous melanoma metastases

1975 • 62 citations

Regression of pulmonary metastatic disease associated with intralesional bcg therapy of intracutaneous melanoma metastases

1975 • 62 citations

Immunoelectronmicroscopic Analysis of Surface Antigens Common to Mycobacterium bovis (BCG) and Tumor Cells2

1974 • 61 citations

THE ADJUVANT EFFECT OF MICROBIAL PRODUCTS ON THE IMMUNE RESPONSE

1976 • 60 citations

Studies on the mechanisms of action of BCG

1976 • 58 citations

Inflammatory cells in solid murine neoplasms. II. Cell types found throughout the course of moloney sarcoma regression or progression

1976 • 57 citations

Radioimmunoassay of Tumour Specific Transplantation Antigen of a Chemically Induced Rat Sarcoma: Circulating Soluble Tumour Antigen in Tumour Bearers

1973 • 57 citations

Antibodies and Soluble Tumour-specific Antigens in Blood and Lymph of Rats with Chemically Induced Sarcomata

1973 • 57 citations

Shared Antigens between Human Malignant Melanoma Cells and Mycobacterium Bovis (BCG)

1976 • 56 citations

IMMUNOTHERAPY OF CANCER WITH CELL WALL SKELETON OF MYCOBACTERIUM BOVIS‐BACILLUS CALMETTE‐GUÉRIN: EXPERIMENTAL AND CLINICAL RESULTS

1976 • 56 citations

Immune Response to Mycobacterium tuberculosis in Rats

1973 • 54 citations

Antigenic Relationship Between Mycobacterium bovis (BCG) and a Guinea Pig Hepatoma

1973 • 54 citations

Macrophages in Solid Tumors. I. Immunologically Specific Effector Cells 2

1974 • 54 citations

Antibodies and antigen expression in human melanoma detected by the immune adherence test

1975 • 53 citations

Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells

1975 • 53 citations

Secondary spread of cancer

1978 • 53 citations

Intra‐tumour host cells of transplanted rat neoplasms of different immunogenicity

1977 • 52 citations

Nonspecific resistance against infection with Salmonella typhi and Salmonella typhimurium induced in mice by cord factor (trehalose-6,6'-dimycolate) and its analogues

1976 • 51 citations

Cell-Mediated Immunity to Human Tumors

1973 • 51 citations

Intralesional BCG in the treatment of metastatic malignant melanoma

1976 • 51 citations

Comparative study on the effects of surgery, chemotherapy, and immunotherapy, alone and in combination, on metastases of the 13762 mammary adenocarcinoma.

1974 • 50 citations

BCG immunotherapy of rat tumours in athymic nude mice

1975 • 50 citations

Serum factors modifying cell mediated immunity to rat hepatoma D23 correlated with tumour growth

1975 • 50 citations

Shared Antigens betweenMycobacterium bovis(BCG) and Other Bacterial Species

1972 • 49 citations

Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase.

1974 • 49 citations

Histopathology of Tumor Regression After Intralesional Injection of <italic>Mycobacterium bovis</italic>. II. Comparative Effects of Vaccinia Virus, Oxazolone, and Turpentine<xref ref-type="fn" rid="FN2">2</xref>

1972 • 49 citations

Cellular immunity in human malignant melanoma and melanoma histology

1973 • 49 citations

Activation of lymphoid cells by BCG in vitro

1975 • 48 citations

Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.

1972 • 47 citations

Soluble tumour‐specific antigen and its relationship to tumour growth

1975 • 46 citations

Antibodies against BCG antigen 60 in mycobacterial infection.

1977 • 46 citations

The questionable immunogenicity of certain neoplasms

1977 • 45 citations

Inflammatory cells in solid murine neoplasms. IV. Cytolytic T lymphocytes isolated from regressing or progressing Moloney sarcomas.

1977 • 45 citations

Stimulation of macrophages by cord factor and by heat-killed and living BCG

1977 • 45 citations

Lymphatic metastasis and its inhibition: An experimental model

1974 • 45 citations

Studies on the Fc receptor bearing cells in a transplanted methylcholanthrene induced mouse fibrosarcoma

1976 • 44 citations

Therapeutic effect of intratumoral injection of BCG and other substances in rats and mice

1975 • 44 citations

Decreased phagocytosis by peritoneal macrophages from BCG-treated mice

1977 • 43 citations

A 5-YEAR CONTROLLED STUDY OF B.C.G. AND RADIOTHERAPY FOR INOPERABLE LUNG CANCER

1976 • 43 citations

BCG Vaccination Against Tuberculosis

1957 • 42 citations

Coupling PPD to tumour cells enhances their antigenicity in BCG-primed mice

1978 • 42 citations

Immunotherapy of patients with cancer.

1973 • 42 citations

Virulence of Six Strains of Mycobacterium bovis (BCG) in Mice

1973 • 41 citations

Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future.

1975 • 40 citations

Tumor resistance in rats immunized to fetal tissues

1974 • 39 citations

Circulating tumor antigens versus immune serum factors in depressed concomitant immunity.

1974 • 39 citations

Kinetics of the response of spleen cells from tumor‐bearing animals in an in vivo tumor neutralization assay

1976 • 39 citations

Present status of BCG immunotherapy of malignant melanoma

1976 • 38 citations

THERAPEUTIC EFFECTIVENESS OF NEURAMINIDASE‐TREATED TUMOR CELLS AS AN IMMUNOGEN IN MAN AND EXPERIMENTAL ANIMALS WITH LEUKEMIA*

1976 • 38 citations

Immunotherapy of breast cancer, malignant melanoma, and acute leukemia with BCG: Prolongation of disease free interval and survival

1976 • 37 citations

Human toxicology of BCG applied in cancer immunotherapy

1976 • 36 citations

Tumor Regression Mediated by Mycobacterium bovis (Strain BCG). Effects of Isonicotinic Acid Hydrazide, Cortisone Acetate, and Antithymocyte Serum

1973 • 35 citations

Use of BCG as an immunostimulant in the surgical treatment of carcinoma of the lung

1974 • 35 citations

B.C.G. suppression of pulmonary metastases from primary rat hepatomata

1974 • 34 citations

Effects of Bcg on Lymphocyte Trapping

1976 • 34 citations

The Current Status of BCG Immunization Against Tuberculosis

1977 • 33 citations

Quantitative studies on cell-mediated immunity in the pleural cavity of guinea-pigs

1975 • 33 citations

Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma

1976 • 33 citations

Sequential quantitation of circulating immune complexes in syngeneic and allogeneic rats bearing Moloney sarcomas.

1977 • 32 citations

Immunogenicity of Rat Hepatoma Membrane Fractions

1973 • 32 citations

Histologic reactions of the thymus, spleen, liver and lymph nodes to intravenous and subcutaneous BCG injections.

1975 • 32 citations

Influence of cell‐free tumour‐associated antigen preparations on the development of immunity to chemically induced rat tumours

1976 • 32 citations

Production and assay of antibodies against one antigenic component of Mycobacterium bovis BCG

1977 • 31 citations

Delayed hypersensitivity in mice

1959 • 31 citations

Nonspecific immunoprevention of L1210 leukemia by cord factor (6-6? dimycolate of trehalose) administered in a metabolizable oil

1976 • 31 citations

Immunogenic Properties of Rat Hepatoma Subcellular Fractions

1974 • 31 citations

Blocking and Unblocking Serum Factors in Neoplasia

1976 • 31 citations

Bcg therapy of pleural and peritoneal growth of transplanted rat tumours

1975 • 30 citations

Murine sarcoma virus (msv)‐induced tumors in mice. I. Distribution of msv‐immune cytolytic t lymphocytes in vivo

1977 • 29 citations

Silica abrogation of mycobacterial adjuvant contact suppression of tumor growth in rats and athymic mice

1976 • 29 citations

Suppression of Growth of Ehrlich Ascites Tumor Cells in Mice by Trehalose-6, 6′ -Dimycolate (Cord Factor) and BCG

1974 • 28 citations

Characteristics of the Immature Cells Involved in T Cell-Mediated Enhancement of Syngeneic Tumor Growth

1977 • 28 citations

Clinical and Histologic Correlation of Melanoma Regression After Intralesional BCG Therapy: A Case Report2

1974 • 28 citations

Effect of bacillus Calmette-Guérin and/or methylcholanthrene on the antibody-forming cells measured at the cellular level by a hemolytic plaque test.

1966 • 28 citations

Brief Communication: Immunotherapy of Cancer: Tumor Suppression and Regression by Cell Walls of Mycobacterium phlei Attached to Oil Droplets2

1975 • 28 citations

Neuraminidase and tumor immunotherapy

1977 • 28 citations

An antigenic analysis of the mycobacteria,Mycobacterium fortuitum,Myco. kansasii,Myco. phlei,Myco. smegmatis andMyco. tuberculosis

1968 • 27 citations

Relevant animal models for tumor immunotherapy

1976 • 27 citations

Direct Comparison of Three Isotopic Release Microtoxicity Assays as Measures of Cell-Mediated Immunity to Gross Virus-Induced Lymphomas in Rats

1977 • 27 citations

BACILLUS CALMETTE‐GUÉRIN CONTACT IMMUNOTHERAPY OF LOCAL AND METASTATIC DEPOSITS OF RAT TUMORS*

1976 • 26 citations

Methanol extraction residue of BCG in the treatment of transplanted rat tumours

1975 • 26 citations

Combination of C. parvum and specific immunization against artificial pulmonary metastases in mice

1975 • 25 citations

Tumour inhibition mediated by BCG in immunosuppressed rats

1975 • 24 citations

STUDIES ON TUBERCLE BACILLUS-HISTIOCYTE RELATIONSHIP

1962 • 24 citations

Eradication of Microscopic Lymph Node Metastases After Injection of Living BeG Adiacent to the Primary Tumor

1975 • 23 citations

BCG treatment of malignant pleural effusions in the rat

1976 • 22 citations

The Role of Immunological Factors in Viral and Oncogenic Processes

1975 • 22 citations

Sequential Quantitation of Circulating Immune Complexes in Syngeneic and Allogeneic Rats Bearing Moloney Sarcomas

1977 • 21 citations

Inflammatory Cells in Solid Murine Neoplasms

1977 • 21 citations

Activation of guinea pig macrophages by cell walls of Mycobacterium bovis, strain BCG

1976 • 21 citations

Circulating immune complexes in rats bearing chemically induced tumors. I. Sequential determination during the growth of tumours at various body sites

1978 • 21 citations

Immunotherapy and vaccination against cancer with non‐living BCG and cord factor (trehalose‐6,6′‐dimycolate)

1975 • 21 citations

ISOLATION AND CHARACTERIZATION OF TUMOUR-SPECIFIC ANTIGEN FROM THE SERUM OF RATS BEARING TRANSPLANTED AMINOAZO DYE-INDUCED HEPATOMAS

1976 • 21 citations

Inhibition of pulmonary tumour development in rats sensitised to rat embryonic tissue

1975 • 20 citations

Immunology and the Melanomas

1974 • 20 citations

Immunopotentiation With BeG: Dimensions of a Specific Antitumor Response2

1975 • 20 citations

Induction of immunity to chemically-induced rat tumours by cellular or soluble antigens

1978 • 19 citations

Evaluation of BCG Administered by Scarification for Immunotherapy of Metastatic Hepatocarcinoma in the Guinea Pig2

1976 • 19 citations

INTRAPLEURAL B.C.G. IMMUNOSTIMULATION IN LUNG CANCER

1977 • 19 citations

<italic>Brief Communication:</italic> BCG Therapy Given as an Adjuvant to Surgery: Prevention of Death From Metastases From Mammary Adenocarcinoma in Rats<xref ref-type="fn" rid="fn2">2</xref>

1974 • 19 citations

Effector cells for antibody-dependent cell mediated cytotoxicity

1977 • 19 citations

The biologic activity of MER-BCG in experimental systems and preliminary clinical studies

1977 • 18 citations

Influence of whole body irradiation on bcg contact suppression of a rat sarcoma and tumour-specific immunity

1976 • 18 citations

Detection of soluble tumor-associated antigens in serum of tumor-bearing rats and their immunological role in vivo.

1977 • 18 citations

Enhanced Tumor Growth in Animals Pretreated with Complete Freund's Adjuvant

1973 • 18 citations

Induction of Tumor-Immune Responses and Their Interaction with the Developing Tumor

1977 • 17 citations

Approaches for the isolation of biologically functional tumor-associated antigens.

1977 • 16 citations

Comparison of various BCG preparations in the EORTC ? ICIG experimental screening for systemic immunity adjuvants applicable to cancer immunotherapy

1976 • 15 citations

Immunotherapy of Cancer With Nonliving Mycobacteria and Cord Factor (Trehalose-6,6′-dimycolate) in Aqueous Medium

1976 • 15 citations

Suppression of transplanted rat sarcomata mediated by Bacillus Calmette Guérin (BCG)

1974 • 15 citations

Influence of immunotherapeutic agents on the progression of spontaneously arising, metastasizing rat mammary adenocarcinomas of varying immunogenicities.

1978 • 15 citations

Trehalose covalently conjugated to bovine serum albumin

1977 • 14 citations

Treatment of the mouse Lewis tumor by the association of radiotherapy and immunotherapy with Bacillus Calmette-Guérin.

1976 • 14 citations

Toxicity studies of intravenously administered BCG in baboons

1976 • 14 citations

Extraction of Tumor-Specific Antigen From Cells and Plasma Membranes of Line-10 Hepatoma

1975 • 14 citations

Generalized Cutaneous Reaction Associated with the Intratumor Injection of BCG

1975 • 14 citations

Immunotherapy of Leukemia

1976 • 14 citations

BCG vaccine in perspective.

1974 • 13 citations

Modulation of the Immune Response of Guinea Pigs by Repeated BCG Scarification

1974 • 13 citations

Tumour rejection in rats sensitized to embryonic tissue. I. Rejection of tumour cells implanted s.c. and detection of cytotoxic lymphoid cells

1976 • 12 citations

Influence of orally administered B.C.G. on growth of transplanted rat tumours

1975 • 12 citations

C. parvum suppression of rat tumours in athymic nude mice

1976 • 12 citations

Antitumor Immunity. V. BCG-Induced Growth Inhibition of Murine Tumors. Effect of Hydrocortisone, Antiserum Against Theta Antigen, and Gamma-Irradiated BCG

1977 • 12 citations

Cytotoxic antibody in acute myeloblastic leukaemia during immunotherapy: Lack of tumour specificity

1977 • 11 citations

Influence of BCG-Potentiated Immunotherapy in Tumor-Bearing Mice 2

1977 • 11 citations

A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.

1976 • 11 citations

Stimulation of Lymphoid Cells by Components of BCG2

1975 • 10 citations

NEW METHOD OF IMMUNOTHERAPY FOR LUNG CANCER

1977 • 10 citations

EFFECT OF INTRAVENOUS B.C.G. IN GUINEAPIGS AND PERTINENCE TO CANCER IMMUNOTHERAPY IN MAN

1975 • 9 citations

Tumour‐associated transplantation antigen in sera of rats with large RSV‐induced sarcomas

1975 • 8 citations

Active Tumor Immunotherapy with BCG

1973 • 8 citations

Studies on the microcytotoxicity test. I. Evidence that the effects of normal lymphoid cells on tumour cell growth in microtest plates may be caused by non‐immunological modifications of the culture medium

1976 • 7 citations

Intra‐lesional injection of immunostimulants in bilateral rat tumors

1976 • 7 citations

Inhibition of transplanted sarcomas mediated by BCG in rats with a defined immunological deficit.

1976 • 7 citations

Stimulation of anti-tumour immunity in guinea-pigs by methanol extraction residue of BCG

1976 • 7 citations

Specific tubercle antigen

1976 • 7 citations

Shared antigens between bacteria and guinea pig line 10 hepatocarcinoma cells.

1976 • 6 citations

Induction of delayed-type hypersensitivity with BCG-associated proteins.

1976 • 6 citations

Serum-Mediated Escape From BeG-Potentiated Antitumor Immunity In Vivo2

1977 • 5 citations

Results in children of acute lymphoid leukaemia protocol ICIG-ALL 9 consisting of chemotherapy for only nine months followed by active immunotherapy

1977 • 5 citations

The effects of BCG on both cellular and humoral immunity during the early response to a hapten carrier complex.

1976 • 5 citations

INTRAPLEURAL B.C.G. TREATMENT OF EXPERIMENTAL LUNG TUMOURS

1976 • 4 citations

Antitumor activity and other biological properties of two phenotypes isolated from BCG

1976 • 4 citations

Differential responsiveness of various substrains of inbred strain 2 guinea pigs to immunotherapy with the methanol extraction residue (MER) of BCG

1977 • 4 citations

Introduction and Definitions

1976 • 4 citations

Resistance to tumor growth in guinea pigs immunized with lyophilized tumor cells

1977 • 3 citations

Induction of tumor resistance with BCGa‐associated tumor antigen

1977 • 2 citations

Failure of Bacillus Calmette-Guérin (BCG) infection to suppress the growth of transplanted mouse and rat sarcomas.

1973 • 2 citations

Cited By (0)

No citing papers found in database

Bcg in Tumor Immunotherapy (1978) – Advances in cancer research | Metascience Observatory Explorer